BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 3035114)

  • 1. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
    Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
    J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
    Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
    Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
    Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
    Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):3-8. PubMed ID: 9002740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
    Shapiro B
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.
    Coutris G; Talbot JN; Kabla G; Calmettes C; Milhaud G
    Eur J Nucl Med; 1986; 12(2):77-9. PubMed ID: 3732310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.
    Feldman JM; Blinder RA; Lucas KJ; Coleman RE
    J Nucl Med; 1986 Nov; 27(11):1691-6. PubMed ID: 3772504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I-MIBG scintigraphy in neural crest tumours.
    Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP
    Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.
    Clarke SE; Lazarus CR; Edwards S; Murby B; Clarke DG; Roden TM; Fogelman I; Maisey MN
    J Nucl Med; 1987 Dec; 28(12):1820-5. PubMed ID: 3681441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
    Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
    Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
    Skowsky WR; Wilf LH
    South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
    Maurea S; Cuocolo A; Reynolds JC; Tumeh SS; Begley MG; Linehan WM; Norton JA; Walther MM; Keiser HR; Neumann RD
    J Nucl Med; 1993 Feb; 34(2):173-9. PubMed ID: 8381474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy of neuroectodermal tumors].
    Adolph J; Kimmig B
    Radiologe; 1989 Jan; 29(1):32-42. PubMed ID: 2537501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
    Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
    Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple chemodectomas. Carotid body tumor masked by salivary gland uptake on I-123 MIBG scintigraphy.
    Weissman AF; Gonzalez CE; Shapiro B; Shulkin B; Francis IR; Leach K
    Clin Nucl Med; 1994 Jun; 19(6):527-31. PubMed ID: 8062474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.
    Bomanji J; Levison DA; Flatman WD; Horne T; Bouloux PM; Ross G; Britton KE; Besser GM
    J Nucl Med; 1987 Jun; 28(6):973-8. PubMed ID: 3585505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsuccessful iodine-131 MIBG imaging of carcinoid tumors and apudomas.
    Sinzinger H; Renner F; Granegger S
    J Nucl Med; 1986 Jul; 27(7):1221-2. PubMed ID: 3723196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.